|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||43.14 - 43.55|
|52 Week Range||33.76 - 46.63|
|Beta (5Y Monthly)||0.30|
|PE Ratio (TTM)||28.25|
|Forward Dividend & Yield||1.14 (2.70%)|
|Ex-Dividend Date||Mar 19, 2020|
|1y Target Est||50.10|
Moody's Investors Service has downgraded the corporate family rating (CFR) and senior unsecured rating of Yestar Healthcare Holdings Company Limited to B3 from B1. For provisional ratings, this announcement provides certain regulatory disclosures in relation to the provisional rating assigned, and in relation to a definitive rating that may be assigned subsequent to the final issuance of the debt, in each case where the transaction structure and terms have not changed prior to the assignment of the definitive rating in a manner that would have affected the rating.
Halozyme (HALO) reports lower-than-expected Q2 earnings. Shares down.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Roche Holding AG and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.